Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Eyes and Vision

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3 · 75%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 25%High 0 · 0%

Phacoemulsification vs phacoemulsification plus goniosynechialysis

Glaucoma progression at 12 months, measured by additional visual field defects · participants with primary angle‐closure glaucoma

The review found no eligible studies for this question.

1 finding from 1 review

Lens extraction for chronic angle‐closure glaucoma 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Phacoemulsification vs phacoemulsification plus viscogonioplasty

Glaucoma progression at 12 months, measured by additional visual field defects · participants with primary angle‐closure glaucoma

The review found no eligible studies for this question.

1 finding from 1 review

Lens extraction for chronic angle‐closure glaucoma 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Phacoemulsification vs phacoemulsification plus trabeculectomy

Glaucoma progression at 12 months, measured by additional visual field defects · participants with primary angle‐closure glaucoma

The review found no eligible studies for this question.

1 finding from 1 review

Lens extraction for chronic angle‐closure glaucoma 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Phacoemulsification vs laser peripheral iridotomy

Progression of visual field loss (worsening of one or more stages, accordingto the Glaucoma Staging System‐2) (at 12 months) · participants with primary angle‐closure glaucoma

Phacoemulsification probably leads to lower progression of visual field loss (worsening of one or more stages,… compared with laser peripheral iridotomy (moderate certainty).

1 finding from 1 review

Lens extraction for chronic angle‐closure glaucoma 2021 · Cochrane Headline outcomes only
OR 0.35 [0.13, 0.91]
Studies not reported
Moderate